List of works by Geoffrey J Gorse

1054Immunogenicity And Safety of Quadrivalent Influenza Vaccine Administered Intradermally (ID) in Adults 18 through 64 Years of Age.

scientific article published in December 2014

1204. Increased Risk of Respiratory Infections Among Healthcare Personnel (HCP) Caring for Children

1205. Healthcare Personnel Knowledge, Attitudes, and Beliefs Towards Infection Prevention and Control Measures for Protection from Respiratory Infections

scientific article published on 23 October 2019

1716. Results of the Respiratory Protection Effectiveness Clinical Trial (ResPECT)

410. Influence of Pre-season Antibody Titers to Influenza on Influenza Risk in a Cohort of Healthcare Personnel

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

scientific article published in August 1999

A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

scientific article published on 01 February 1996

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.

scientific article

Anaerobic endocarditis caused by Staphylococcus saccharolyticus

scientific article

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group

scientific article published in February 1998

Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses

scientific article published on 03 March 2020

Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.

scientific article

Association of malnutrition with nosocomial infection

scientific article

Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network

scientific article published in March 1993

Bacterial meningitis in the elderly

scientific article published on 01 August 1984

Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection

scientific article published on January 2004

CNS infection and bacteremia due to clostridium septicum

scientific article published in August 1984

Canarypox vaccines induce antigen-specific human gammadelta T cells capable of interferon-gamma production.

scientific article

Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1.

scientific article

Characteristics of a population volunteering for human immunodeficiency virus immunization. NIAID AIDS Clinical Trials Network

scientific article

Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein

scientific article published on 15 March 2004

Comparison of the immune response to recombinant gp120 in humans and chimpanzees

scientific article published in May 1994

Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals

scientific article

Coronavirus and Other Respiratory Illnesses Comparing Older with Young Adults

scientific article published on 15 June 2015

Current progress in HIV vaccines

scientific article published on November 1, 1991

Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1(SF-2) recombinant GP120.

scientific article published in February 2001

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group

scientific article published in February 1998

DNA and modified vaccinia virus Ankara vaccines encoding multiple cytotoxic and helper T-lymphocyte epitopes of human immunodeficiency virus type 1 (HIV-1) are safe but weakly immunogenic in HIV-1-uninfected, vaccinia virus-naive adults

scientific article

Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Networ

scientific article published on October 1992

Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network

scientific article

Effect of antineoplastic agents on gamma-interferon production in human peripheral blood mononuclear cells

scientific article published on 01 November 1984

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

scientific article published in July 1999

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study

scientific article published in May 2003

Enhanced Potency and Durability of Antibody Response to Seasonal Trivalent Inactivated Influenza Vaccine (TIV) Combined with a Novel Water-in-Oil Adjuvant System at Reduced Hemagglutinin (HA) Doses.

scientific article published on 4 October 2017

Enhanced lymphoproliferation to influenza A virus following vaccination of older, chronically ill adults with live-attenuated viruses

scientific article

Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults

scientific article

Genetic and Immunologic Characterization of Viruses Infecting MN‐rgp120‐Vaccinated Volunteers ⬇️

scientific article published on August 1, 1997

HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers.

scientific article

HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network

scientific article published on 01 November 1994

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network

scientific article published on 01 February 1995

HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

scientific article

Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease.

scientific article published in March 2009

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

scientific article published in May 1998

Immunity to influenza in older adults with chronic obstructive pulmonary disease

scientific article published on 26 May 2004

Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women

scientific article published in October 1999

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

scientific article published in February 1996

Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial

scientific article published on 11 October 2013

Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial

scientific article published on 05 June 2006

Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination

scientific article published in October 2006

Impact of mandatory vaccination of healthcare personnel on rates of influenza and other viral respiratory pathogens

journal article published in 2022

Impact of removing gentamicin from an antibiotic restriction program

scientific article published in October 1985

Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine

scientific article

Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine

scientific article published on 01 July 1993

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group

scientific article published in December 1998

Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly

scientific article published in February 1996

Infection Control Practices in Gastrointestinal Endoscopy in the United States: A National Survey

scientific article published on 01 May 1991

Influence of preseason antibodies against influenza virus on risk of influenza infection among healthcare personnel

journal article published in 2022

Influenza virus vaccination of patients with chronic lung disease

scientific article published in November 1997

Interpatient mutational spectrum of human coronavirus-OC43 revealed by illumina sequencing.

scientific article published on 12 February 2017

Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.

scientific article published on 13 March 2013

Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines

scientific article published on May 1988

Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials Network

scientific article published on January 1, 1992

MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates. National Institute of Allergy and Infectious Disease Aids Vaccine Evaluation Group

scientific article published in July 1999

Male genital tuberculosis: a review of the literature with instructive case reports

scientific article

Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

scientific article published on 01 March 1998

N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial

journal article published in 2019

Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network

scientific article published on 01 August 1994

Nontuberculous mycobacterial disease. Experience in a southern California hospital

scientific article published on February 1, 1983

Outpatient healthcare personnel knowledge and attitudes towards infection prevention measures for protection from respiratory infections

journal article published in 2021

Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants

scientific article

Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum ⬇️

scientific article published on October 13, 2010

Protecting healthcare personnel in outpatient settings: the influence of mandatory versus nonmandatory influenza vaccination policies on workplace absenteeism during multiple respiratory virus seasons

journal article published in 2018

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

article

Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older

scientific article published on July 2009

Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine

scientific article published on 8 January 2003

Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein. NIAID AIDS Vaccine Clinical Trials Network

scientific article published on 01 September 1995

Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial.

scientific article

Response to letter to the editor "Zink TK. Vaccine 2007;25(15):2766-7"

scientific article published on 27 August 2007

Risk factors for healthcare personnel infection with endemic coronaviruses (HKU1, OC43, NL63, 229E): results from the Respiratory Protection Effectiveness Clinical Trial (ResPECT)

journal article published in 2021

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers

scientific article published on 10 April 2001

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group

scientific article published on 01 August 1996

Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network.

scientific article published in December 1993

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.

scientific article

Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults

scientific article published on 19 January 2015

Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults

scientific article published on 20 November 2007

Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age.

scientific article published on 20 September 2013

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors

scientific article published on 01 September 2001

Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases

scientific article published on September 1986

Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group

scientific article published on 01 September 1997

Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation Group

scientific article

Specific activation strategies for amplification of low CTL signals

scientific article published on 01 August 1992

Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults

scientific article

Take-home kits to detect respiratory viruses among healthcare personnel: lessons learned from a cluster randomized clinical trial

journal article published in 2021

The Influence of Mandatory Vs. Non-Mandatory Influenza Vaccination Policies on Workplace Absenteeism During Respiratory Virus Season.

scientific article published on 4 October 2017

The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster-randomized comparison of respirator and medical mask effectiveness against respiratory infections in healthcare personnel

journal article published in 2016

The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network

scientific article published in January 1991

Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network

scientific article published on August 1, 1992

Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network

scientific article published in August 1994

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

scientific article published in December 1999

Vaccine-specific antibody responses induced by HIV-1 envelope subunit vaccines

scientific article published on 01 April 1997

Paulina is supported by:

About Paulina

Help